{"url_path":"/sec/cik-0001569064/13dg/2026-05-12/000091957426002901","section_key":"body","section_title":"SCHEDULE 13G body","topic":"sec","document":{"doc_type":"SCHEDULE 13G","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1569064/0000919574-26-002901-index.html","accession_number":"0000919574-26-002901","cik":"0001569064","ticker":null,"issuer_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1569064/0000919574-26-002901-index.html","primary_entity_key":"0001569064","primary_entity_name":"SUVRETTA CAPITAL MANAGEMENT, LLC"},"word_count":65,"has_tables":true,"body_markdown":"EX-99\n2\nd12155622_ex99-a.htm\n\nExhibit A\n\nJOINT FILING AGREEMENT\n\nThe undersigned agree that\nthis Schedule 13G dated May 12, 2026 relating to the Common Stock, par value $0.001 per share, of Replimune Group, Inc. shall be filed\non behalf of the undersigned.\n\nSUVRETTA CAPITAL MANAGEMENT, LLC\n\nBy: /s/ Andrew Nathanson\n\nName: Andrew Nathanson\n\nTitle: General Counsel and Chief Compliance Officer\n\nAARON COWEN\n\nBy: /s/ Aaron Cowen"}